ARN-3236

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameARN-3236
Drug Alias NameARN-3236
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase SIK2 inhibitors
TargetsSerine/threonine-protein kinase SIK2
Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArrien Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A